


Healthcare Industry News: HIV/AIDS
News Release - June 20, 2016
Sangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II
Source: Sangamo BioSciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
